
with  an  actual  physical  measure  is  not  surprising. 
Despite  this  fact,  UPDRS  III  was  chosen  for  the 
validation because it is the clinical golden standard 
for  diagnosis  and  prognosis.  The  correlation  study 
revealed  that  the  fine  movements  like  pinching 
expresses bradykinesia well. Further testing of linear 
model  showed  that  this  method is  less error-prone 
than the UPDRS. If a physician makes 1 scale-unit 
error  for  each item,  the  error becomes  
 
which  is  a  value  much  larger  than  our  proposed 
model’s error. 
5  CONCLUSION 
The  study  proved  that  a  commercially  available 
cheap Leap Motion device can be used to measure 
bradykinesia  level  from  simple  motor  tasks.  In 
comparison  to  UPDRS  scoring  relying  on  the 
physicians’ observations, it provides repeatable and 
quantitative  measurements.  These  two  major 
advantages of technique make it suitable for research 
purposes  where  the  detection  of  subtle  changes  in 
symptoms  is  required.  The  possibility  of  using  a 
COTS  device  can  be  an  invaluable  asset  for  other 
researchers.  With  further  investigations  such  as 
comparison  with  the  results  of  another  clinical 
physiologic sensor, Leap Motion can be converted to 
the  household  self-assessment  device.  Unfortuna-
tely, in our study, the data exclusion rate was high, 
which  calls  for  attention  to  investigate  further  the 
applicability of this procedure in the clinic. 
REFERENCES 
Blandini, F., Nappi, G., Tassorelli, C. and Martignoni, E. 
(2000).  Functional  changes  of  the  basal  ganglia 
circuitry  in  Parkinson's  disease.  Progress  in 
Neurobiology, 62(1), pp.63-88. 
Calne,  D.,  Snow,  B.  and  Lee,  C.  (1992).  Criteria  for 
diagnosing  Parkinson's disease. Annals of Neurology, 
32(S1), pp.S125-S127. 
Daneault,  J.,  Carignan,  B.,  Sadikot,  A.  and  Duval,  C. 
(2013).  Are  quantitative  and  clinical  measures  of 
bradykinesia related in advanced Parkinson's disease?. 
Journal of Neuroscience Methods, 219(2), pp.220-223. 
Dunnewold,  R.,  Jacobi,  C.  and  van  Hilten,  J.  (1997). 
Quantitative  assessment  of  bradykinesia  in  patients 
with  Parkinson's  disease.  Journal  of  Neuroscience 
Methods, 74(1), pp.107-112. 
Fahn,  S.,  Marsden,  C.,  Goldstein,  M.  and  Calne,  D. 
(1987).  Recent  developments  in  Parkinson's  disease. 
Volume  2.  Florham  Park:  Macmillan  Healthcare 
Information, pp.153–163. 
Ghassemi,  M.,  Lemieux,  S.,  Jog,  M.,  Edwards,  R.  and 
Duval,  C.  (2006).  Bradykinesia  in  patients  with 
Parkinson's  disease  having  levodopa-induced 
dyskinesias. Brain Research Bulletin, 69(5), pp. 512-
518. 
Kandori, A., Yokoe, M., Sakoda, S., Abe, K., Miyashita, 
T., Oe, H., Naritomi,  H., Ogata,  K. and Tsukada, K. 
(2004).  Quantitative  magnetic  detection  of  finger 
movements  in  patients  with  Parkinson’s  disease. 
Neuroscience Research, 49(2), pp.253-260. 
Marsili, L., Agostino, R., Bologna, M., Belvisi, D., Palma, 
A.,  Fabbrini,  G.  and  Berardelli,  A.  (2014). 
Bradykinesia  of  posed  smiling  and  voluntary 
movement  of  the  lower  face  in  Parkinson's  disease. 
Parkinsonism  &  Related  Disorders,  20(4),  pp.  370-
375. 
Salarian,  A.,  Russmann,  H.,  Wider,  C.,  Burkhard,  P., 
Vingerhoets,  F.  and  Aminian,  K.  (2007). 
Quantification  of  Tremor  and  Bradykinesia  in 
Parkinson's  Disease  Using  a  Novel  Ambulatory 
Monitoring System. IEEE Transactions on Biomedical 
Engineering, 54(2), pp.313-322. 
Sande de Souza, L., Dionísio, V. and Almeida, G. (2011). 
Multi-joint  movements  with  reversal  in  Parkinson’s 
disease: Kinematics and electromyography. Journal of 
Electromyography  and  Kinesiology,  21(2),  pp.376-
383. 
Weichert,  F., Bachmann, D.,  Rudak, B.  and  Fisseler,  D. 
(2013).  Analysis of  the  Accuracy and  Robustness  of 
the Leap Motion Controller. Sensors, 13(5), pp.6380-
6393. 
BIOSIGNALS 2018 - 11th International Conference on Bio-inspired Systems and Signal Processing
232